153 related articles for article (PubMed ID: 32982276)
1. The Potential Action of Thomsen-Friedenreich Monoclonal Antibody (A78-G/A7) in Thyroid Cancer.
Peng Y; Zhan XX; Cao Y; Zhang HW; Cao WH; Su YJ; Diao C; Sun QM; Cheng RC
Onco Targets Ther; 2020; 13():8677-8689. PubMed ID: 32982276
[TBL] [Abstract][Full Text] [Related]
2. Immunoreactivity of monoclonal antibody BW835 represents a marker of progression and prognosis in early gastric cancer.
Baldus SE; Zirbes TK; Glossmann J; Fromm S; Hanisch FG; Mönig SP; Schröder W; Schneider PM; Flucke U; Karsten U; Thiele J; Hölscher AH; Dienes HP
Oncology; 2001; 61(2):147-55. PubMed ID: 11528254
[TBL] [Abstract][Full Text] [Related]
3. Thomsen-Friedenreich antigen presents as a prognostic factor in colorectal carcinoma: A clinicopathologic study of 264 patients.
Baldus SE; Zirbes TK; Hanisch FG; Kunze D; Shafizadeh ST; Nolden S; Mönig SP; Schneider PM; Karsten U; Thiele J; Hölscher AH; Dienes HP
Cancer; 2000 Apr; 88(7):1536-43. PubMed ID: 10738210
[TBL] [Abstract][Full Text] [Related]
4. A new monoclonal antibody (A78-G/A7) to the Thomsen-Friedenreich pan-tumor antigen.
Karsten U; Butschak G; Cao Y; Goletz S; Hanisch FG
Hybridoma; 1995 Feb; 14(1):37-44. PubMed ID: 7539400
[TBL] [Abstract][Full Text] [Related]
5. Immunoreactivity of Thomsen-Friedenreich (TF) antigen in human neoplasms: the importance of carrier-specific glycotope expression on MUC1.
Baldus SE; Hanisch FG; Monaca E; Karsten UR; Zirbes TK; Thiele J; Dienes HP
Histol Histopathol; 1999 Oct; 14(4):1153-8. PubMed ID: 10506931
[TBL] [Abstract][Full Text] [Related]
6. Expression of the Thomsen-Friedenreich (TF) antigen in the human placenta.
Richter DU; Jeschke U; Makovitzky J; Goletz S; Karsten U; Briese V; Friese K
Anticancer Res; 2000; 20(6D):5129-33. PubMed ID: 11326683
[TBL] [Abstract][Full Text] [Related]
7. Development, characterization, and immunotherapeutic use of peptide mimics of the Thomsen-Friedenreich carbohydrate antigen.
Heimburg-Molinaro J; Almogren A; Morey S; Glinskii OV; Roy R; Wilding GE; Cheng RP; Glinsky VV; Rittenhouse-Olson K
Neoplasia; 2009 Aug; 11(8):780-92. PubMed ID: 19649208
[TBL] [Abstract][Full Text] [Related]
8. Coexpression of MUC1 mucin peptide core and the Thomsen-Friedenreich antigen in colorectal neoplasms.
Baldus SE; Hanisch FG; Kotlarek GM; Zirbes TK; Thiele J; Isenberg J; Karsten UR; Devine PL; Dienes HP
Cancer; 1998 Mar; 82(6):1019-27. PubMed ID: 9506345
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of Thomsen-Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients.
Schindlbeck C; Jeschke U; Schulze S; Karsten U; Janni W; Rack B; Krajewski S; Sommer H; Friese K
Breast Cancer Res Treat; 2007 Jan; 101(1):17-25. PubMed ID: 16807671
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody BW835 defines a site-specific Thomsen-Friedenreich disaccharide linked to threonine within the VTSA motif of MUC1 tandem repeats.
Hanisch FG; Stadie T; Bosslet K
Cancer Res; 1995 Sep; 55(18):4036-40. PubMed ID: 7545084
[TBL] [Abstract][Full Text] [Related]
11. Binding of galectin-1 (gal-1) to the Thomsen-Friedenreich (TF) antigen on trophoblast cells and inhibition of proliferation of trophoblast tumor cells in vitro by gal-1 or an anti-TF antibody.
Jeschke U; Karsten U; Wiest I; Schulze S; Kuhn C; Friese K; Walzel H
Histochem Cell Biol; 2006 Oct; 126(4):437-44. PubMed ID: 16607538
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of liver metastases from neuraminidase-treated colon 26 cells by an anti-Thomsen-Friedenreich-specific monoclonal antibody.
Shigeoka H; Karsten U; Okuno K; Yasutomi M
Tumour Biol; 1999; 20(3):139-46. PubMed ID: 10213921
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of spontaneous breast cancer metastasis by anti-Thomsen-Friedenreich antigen monoclonal antibody JAA-F11.
Heimburg J; Yan J; Morey S; Glinskii OV; Huxley VH; Wild L; Klick R; Roy R; Glinsky VV; Rittenhouse-Olson K
Neoplasia; 2006 Nov; 8(11):939-48. PubMed ID: 17132226
[TBL] [Abstract][Full Text] [Related]
14. Expression of Thomsen-Friedenreich (TF) antigens on lymphocytes. I. Distribution of cryptic and exposed TF antigens on murine lymphocytes from different lymphoid organs: detection with an anti-TF monoclonal antibody and peanut agglutinin.
Wolf MF; Schmitt HR; Schumacher K
Cell Immunol; 1989 Jul; 121(2):360-5. PubMed ID: 2736629
[TBL] [Abstract][Full Text] [Related]
15. Anti-Thomsen-Friedenreich-Ag (anti-TF-Ag) potential for cancer therapy.
Almogren A; Abdullah J; Ghapure K; Ferguson K; Glinsky VV; Rittenhouse-Olson K
Front Biosci (Schol Ed); 2012 Jan; 4(3):840-63. PubMed ID: 22202095
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of Thomsen-Friedenreich antigens during tumor progression in breast cancer patients.
Wolf MF; Ludwig A; Fritz P; Schumacher K
Tumour Biol; 1988; 9(4):190-4. PubMed ID: 3420374
[TBL] [Abstract][Full Text] [Related]
17. Postoperative change of anti-Thomsen-Friedenreich and Tn IgG level: the follow-up study of gastrointestinal cancer patients.
Smorodin EP; Kurtenkov OA; Sergeyev BL; Kodar KE; Chuzmarov VI; Afanasyev VP
World J Gastroenterol; 2008 Jul; 14(27):4352-8. PubMed ID: 18666325
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of disseminated tumor cells in the bone marrow of breast cancer patients by the Thomsen-Friedenreich tumor antigen.
Schindlbeck C; Jeschke U; Schulze S; Karsten U; Janni W; Rack B; Sommer H; Friese K
Histochem Cell Biol; 2005 Jun; 123(6):631-7. PubMed ID: 15889266
[TBL] [Abstract][Full Text] [Related]
19. Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and InVitro Efficacy Analysis.
Tati S; Fisk JC; Abdullah J; Karacosta L; Chrisikos T; Philbin P; Morey S; Ghazal D; Zazala F; Jessee J; Quataert S; Koury S; Moreno D; Eng JY; Glinsky VV; Glinskii OV; Sesay M; Gebhard AW; Birthare K; Olson JR; Rittenhouse-Olson K
Neoplasia; 2017 Sep; 19(9):716-733. PubMed ID: 28830009
[TBL] [Abstract][Full Text] [Related]
20. Binding of galectin-1 to breast cancer cells MCF7 induces apoptosis and inhibition of proliferation in vitro in a 2D- and 3D- cell culture model.
Geiger P; Mayer B; Wiest I; Schulze S; Jeschke U; Weissenbacher T
BMC Cancer; 2016 Nov; 16(1):870. PubMed ID: 27825375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
